Showing results (91-100 of 5,223) with videos related to
Sort By:
Pageof 523
Neuron|July 21, 2022
The role of hippocampal KCNQ2 channel in antidepressant actions of ketamineLi Ma, Kenji HashimotoAnnals of General Psychiatry|April 27, 2010
Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five casesTsutomu Furuse, Kenji HashimotoExpert Review of Neurotherapeutics|December 5, 2018
An update on ketamine and its two enantiomers as rapid-acting antidepressantsKai Zhang, Kenji HashimotoThe International Journal of Neuropsychopharmacology|November 21, 2017
Lack of Antidepressant Effects of (2R,6R)-Hydroxynorketamine in a Rat Learned Helplessness Model: Comparison with (R)-KetamineYukihiko Shirayama, Kenji HashimotoInternational Journal of Molecular Sciences|May 14, 2022
Soluble Epoxide Hydrolase as a Therapeutic Target for Neuropsychiatric DisordersJiajing Shan, Kenji HashimotoAdvances in Experimental Medicine and Biology|April 26, 2026
Rethinking the Treatment-Resistant DepressionYunfei Tan, Kenji HashimotoMolecular Psychiatry|November 25, 2021
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamineWei Yao, Qianqian Cao, Shilin Luo, et al.Psychopharmacology|November 16, 2016
Antidepressant effects of combination of brexpiprazole and fluoxetine on depression-like behavior and dendritic changes in mice after inflammationMin Ma, Qian Ren, Chun Yang, et al.Scientific Reports|December 20, 2016
Adjunctive treatment of brexpiprazole with fluoxetine shows a rapid antidepressant effect in social defeat stress model: Role of BDNF-TrkB signalingMin Ma, Qian Ren, Chun Yang, et al.Pharmacology, Biochemistry, and Behavior|February 20, 2016
Effects of escitalopram, R-citalopram, and reboxetine on serum levels of tumor necrosis factor-α, interleukin-10, and depression-like behavior in mice after lipopolysaccharide administrationChao Dong, Ji-chun Zhang, Wei Yao, et al.Pageof 523